Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression
Molecular Therapy
· Elsevier
Аннотация
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Linda Zeng, Jingxian Shu, Shuping Zhong, Xin Dong, Yongjian Wu, Xi Huang
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Поиск и разработка лекарств»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S152500162600763X?dgcid=rss_sd_all
Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S152500162600763X?dgcid=rss_sd_all
“Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression.” Molecular Therapy.
@article{article108296,
title = {Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S152500162600763X?dgcid=rss_sd_all}
}